U.S. Capital Markets Stock News

Waste Connections (WCN) shares were in focus after first quarter 2026 results topped expectations, with management reaffirming full year guidance and pointing to benefits from solid waste pricing, special waste volumes, and AI driven pricing tools. See our latest analysis for Waste Connections. Despite the upbeat first quarter, the recent share price has been weaker, with a 30 day share price return of 2.92% and a year to date share price return of 7.40%. The 1 year total shareholder return...

Wondering if Sabra Health Care REIT at around US$20.36 is offering good value or if the easy money has already been made? This article walks through what the current price might be implying about the stock. Sabra's share price sits at US$20.36, with returns of 1.3% over 7 days, 2.5% over 30 days, 6.3% year to date and 24.7% over the past year, plus 127.5% over 3 years and 71.5% over 5 years. Recent news flow around Sabra has focused on its role as a health care focused REIT and how investors...

Equity Residential, NYSE:EQR, is reportedly in early talks with AvalonBay about a potential merger. The discussions involve two of the largest apartment REITs in the US and relate to combining their residential portfolios. If pursued, the deal could be one of the largest in US real estate, with implications for scale and operations across major apartment markets. For Equity Residential, the news comes with the shares at $65.17 and a mixed recent return profile. The stock is up 4.7% over the...

Wondering whether Smithfield Foods at US$26.29 is offering good value or asking too much? This article walks you through what the current share price actually reflects. Over the past week the stock has seen a 10.4% decline, although it remains up 18.7% year to date and 19.5% over the last year. These movements can change how you think about both opportunity and risk. Recent coverage has focused on how Smithfield Foods fits into broader shifts in the US food sector and what that might mean...

In late April 2026, Genuine Parts Company amended its syndicated credit facility to add US$500 million of Initial Term Loan A and US$500 million of Delayed Draw Term Loan capacity maturing in October 2027, while its board declared a regular quarterly dividend of US$1.0625 per share payable on July 2, 2026. At the same time, management reaffirmed its 2026 earnings outlook and continued a 70-year streak of annual dividend increases, while advancing plans to separate its automotive and...

If you are wondering whether Watsco is priced attractively or already reflecting high expectations, the recent share performance gives you some useful clues before you dig into the valuation work. The stock closed at US$428.57, with a 2.7% pullback over the last week, a 15.7% gain over 30 days, a 23.4% return year to date, and a 6.4% decline over the past year. This mix can point to shifting views on both growth potential and risk. Recent attention around Watsco has focused on its position...

Everest Group, Ltd. reported past first-quarter 2026 earnings with revenue of US$4.07 billion, down from US$4.26 billion a year earlier, while net income rose to US$653 million and basic earnings per share from continuing operations increased to US$16.21. The quarter underscored Everest’s emphasis on profitability and capital efficiency, as improved underwriting performance and higher-margin business mix lifted earnings despite weaker top-line revenue. Next, we’ll examine how this...

If you are wondering whether EOG Resources at around US$138.95 is offering fair value or a potential bargain, it helps to start by lining up what the recent share price is telling you against a few simple valuation checks. The stock has returned 4.4% over the last 7 days, while the 30 day return sits at a 2.6% decline, and over longer periods it has returned 29.5% year to date, 29.8% over 1 year, 35.3% over 3 years, and 114.0% over 5 years. Recent coverage has focused on EOG Resources as a...

Investors may be wondering if Avis Budget Group at around US$185 per share still offers value after its big run, or if the easy money has already been made. The stock has pulled back with a 9.0% decline over the last week and a 2.6% decline over the last month, yet it still shows returns of 44.7% year to date and 92.9% over the past year. Recent coverage has focused on how the share price sits after strong multi year returns, and what that means for investors coming in now. Commentators have...

In the first quarter of 2026, AXIS Capital Holdings Limited reported revenue of US$1,643.63 million and net income of US$254.77 million, with earnings per share from continuing operations rising versus the same period a year earlier. Management credited the stronger results to disciplined underwriting, premium growth in short-tail and specialty lines, and efficiency gains from technology and AI-driven underwriting platforms, alongside continued capital return actions. Now we’ll explore how...

Darling Ingredients (NYSE:DAR) reported a fundamental turnaround in Q1 2026, returning to net profitability. Margins improved across both the core business and the Diamond Green Diesel joint venture. Management linked the shift to favorable regulation, tighter operations, and a more constructive outlook for earnings and cash flow. For investors following Darling Ingredients, the Q1 2026 results mark a clear reset in the story around NYSE:DAR. The share price sits at $63.77, with the stock...

PriceSmart, Inc. has released its Fiscal Year 2025 Sustainability Report, highlighting extensive solar power adoption across 48 of its 56 warehouse clubs and detailing plans, already announced and now underway, to open five additional clubs that would bring its network to 61 locations. The report also outlines the Women@PriceSmart program, signaling a stronger focus on workforce development and gender inclusion alongside the company’s physical expansion. We’ll now examine how PriceSmart’s...

If you are wondering whether Haemonetics at around US$59.26 is a bargain or just fairly priced right now, this article walks through what the numbers say about its value. The stock has seen mixed returns, with a 1.1% decline over the last 7 days, a 4.3% gain over 30 days, and year to date and 1 year returns of 25.9% and 7.2% declines. These movements may be prompting new questions about risk and opportunity. Recent news coverage has focused on Haemonetics as part of broader discussions...

In the first quarter of 2026, Iridium Communications Inc. reported revenue of US$219.06 million versus US$214.88 million a year earlier, while net income fell to US$21.59 million from US$30.41 million and diluted EPS from continuing operations eased to US$0.20 from US$0.27. Iridium also reiterated its 2026 outlook for total service revenue to be flat to 2%, signaling a cautious near-term growth profile despite higher quarterly sales. With Iridium reaffirming expectations for flat to slightly...

What Landstar’s latest quarter tells you Landstar System (LSTR) just released first quarter results, with sales of US$1,149.56 million and net income of US$39.44 million, and reported basic EPS from continuing operations of US$1.16. Management also highlighted heavy haul revenue, lower insurance and claims costs, AI-related initiatives, and a focus on U.S. Mexico cross border freight and carrier vetting, giving investors more context than the headline numbers alone. See our latest analysis...

How H.B. Fuller Stock Has Been Trading Recently H.B. Fuller (FUL) has seen relatively muted share performance lately, with the stock around $59.95 and negative returns over the past week, month, and past 3 months, despite a positive 1 year total return. For context, the company carries a market value of about $3.27b and generates annual revenue of roughly $3.46b with net income of about $159.76m. This reflects its role as an established adhesives and specialty chemicals supplier. See our...

Kodiak Sciences (KOD) is back in focus after sharing new KSI-101 clinical data in Asian MESI patients at the AUS and ARVO meetings, reinforcing interest in its expanding retinal disease pipeline. See our latest analysis for Kodiak Sciences. The clinical updates around KSI-101 arrive after a sharp re-rating in Kodiak Sciences, with the share price at US$43.96 and a 90-day share price return of 82.33%, contributing to a very large 1-year total shareholder return, while the 5-year total...

HCA Healthcare (NYSE:HCA) is opening a new full-service hospital in Gainesville, the first new facility of its kind in the area in more than 50 years. The company is planning a substantial expansion at Kendall Hospital in Miami-Dade, aimed at increasing capacity and service reach in South Florida. Cynthia Cifuentes-Finkel has been appointed senior vice president of marketing and corporate affairs, with responsibility for brand leadership and stakeholder engagement. For investors watching...

If you are wondering whether A10 Networks at around US$26.85 is priced attractively or already baking in a lot of optimism, this breakdown is designed to help you frame that question clearly. The stock has seen a 2.6% decline over the last 7 days, alongside returns of 11.9% over 30 days, 54.8% year to date, 65.9% over 1 year, 104.3% over 3 years and 214.4% over 5 years. These movements can change how the market views both its potential and its risks. Recent coverage has focused on A10...

Chime Financial (NasdaqGS:CHYM) has partnered with Junior Achievement USA to roll out AI powered financial literacy programs for students. The partnership includes a redesign of the JA Finance Park program to introduce interactive, experiential money management and career readiness modules. The initiative launches during Financial Literacy Month and focuses on preparing young people for real world financial decisions. For investors tracking Chime Financial, the partnership arrives as the...

Rezolve AI's SQD token has been listed on Revolut, expanding access to more than 70 million users worldwide. The listing brings SQD onto a large mainstream fintech platform, beyond crypto focused exchanges. This move is positioned as a step toward mass market adoption of Rezolve AI's decentralized AI commerce infrastructure. Rezolve AI, listed as NasdaqGM:RZLV, is building a decentralized AI commerce infrastructure designed to connect agentic AI systems with real world transactional data...

Erasca (NasdaqGS:ERAS) disclosed a patient death in its Phase 1 ERAS-0015 trial, triggering heightened safety and regulatory scrutiny. Revolution Medicines filed a patent infringement lawsuit against Erasca, also challenging the way ERAS-0015 has been compared to its own programs. These events follow a recent preliminary positive data update for ERAS-0015 and introduce fresh uncertainty around the asset and broader pipeline. Erasca comes into this twin shock with a share price of $10.03 and...

If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, the starting point is understanding what the current share price really reflects. The stock most recently closed at US$513.72, with returns of 0.3% over 7 days, a 6.1% decline over 30 days, a 13.5% decline year to date, a 62.8% return over 1 year, a 67.7% return over 3 years, and a very large 5 year gain of 293.9%. These mixed short term and longer term moves have kept Madrigal on the radar of...

Wondering whether Clarivate at US$2.79 is a bargain or a value trap? This article breaks down what that price really implies about the business. The stock has moved 13.9% over the last 7 days and 10.3% over the last 30 days, while the year to date return is 13.9% and the 1 year return is 35.4%. Recent coverage has focused on Clarivate's role within professional services and the information solutions space, with attention on how its products fit into clients' long term workflows and budgets...